Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 2;7(2):437-443.
doi: 10.1093/jalm/jfab110.

Alternative Causes of Infectious Diarrhea in Patients with Negative Tests for Clostridoides Difficile

Jennie H Kwon  1 , Caroline A O'Neil  1 , Tiffany Hink  1 , Kimberly A Reske  1 , Rachel E Bosserman  1 , Erik R Dubberke  1 , Carey-Ann D Burnham  2
Affiliations

Alternative Causes of Infectious Diarrhea in Patients with Negative Tests for Clostridoides Difficile

Jennie H Kwon et al. J Appl Lab Med. .

Abstract

Background: Hospitalized patients with diarrhea who have a negative Clostridoides difficile (C. difficile) test are not routinely evaluated for alternative causes of infectious diarrhea. This study assessed for potential infectious causes of diarrhea in hospitalized patients with an order for repeat C. difficile toxin enzyme immunoassay (tEIA) testing after an initial tEIA test was negative.

Methods: For patients age ≥18 years who had a second C. difficile tEIA test ordered within 96 h after a negative tEIA test, remnant fecal specimens from the first (negative) tEIA test were evaluated using the BioFire FilmArray Gastrointestinal Panel PCR, C. difficile toxigenic culture, and culture on a blood agar plate (BAP) to identify other potential causes of infectious diarrhea. Growth of organisms on the BAP was also used to assess potential disruptions in the gastrointestinal microbiota.

Results: Among 84 remnant specimens, toxigenic C. difficile was identified in 9 (11%) by culture or PCR, while potential alternative causes of infectious diarrhea, including norovirus, rotavirus, enteropathogenic Escherichia coli, and Salmonella, were identified in 11 specimens (13%) by PCR. For the majority of patients, no infectious cause of diarrhea was identified, but 84% exhibited disrupted gastrointestinal microbiota, which may contribute to diarrhea.

Conclusions: When a hospitalized patient has a negative C. difficile tEIA test but continues to have diarrhea, alternative infectious and noninfectious causes of diarrhea should be considered. If the patient has clinical signs and symptoms suggestive of infection or risk factors for gastrointestinal infection, laboratory testing for other etiologic agents may be appropriate.

Keywords: Clostridoides difficile; diarrhea; infectious diarrhea.

PubMed Disclaimer

References

    1. McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, et al.Clinical Practice Guidelines for Clostridium difficile infection in adults and children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018;66:e1–48. - PMC - PubMed
    1. Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K, et al.2017 Infectious Diseases Society of America Clinical Practice Guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis 2017;65:e45–80. - PMC - PubMed
    1. Beal SG, Velez L, Tremblay EE, Toffel S, Rand KH.. The “3-day rule” for stool tests may not apply when using PCR panels. J Clin Microbiol 2018;56:e02012–17. - PMC - PubMed
    1. Kwon JH, Reske KA, Hink T, Jackups R, Burnham CD, Dubberke ER.. Impact of an electronic hard-stop clinical decision support tool to limit repeat Clostridioides difficile toxin enzyme immunoassay testing on test utilization. Infect Control Hosp Epidemiol 2019;40:1–4. - PMC - PubMed
    1. Dubberke ER, Reske KA, Hink T, Kwon JH, Cass C, Bongu J, et al.Clostridium difficile colonization among patients with clinically significant diarrhea and no identifiable cause of diarrhea. Infect Control Hosp Epidemiol 2018;39:1330–3. - PMC - PubMed

Publication types